Min Son of Hanol IP & Law says pharmaceutical R&D in South Korea should be enhanced on the introduction of a clearer legal framework that offers improved market protection for new and modified drugs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback